3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Non-Small Cell Lung Cancer ALK-positive
1
Lung Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer
1
Advanced Non-Small Cell Lung Cancer
1
ALK Positive Non-small Cell Lung Cancer
1
Interventions
Magnetic Resonance Spectroscopy
14
Temozolomide
11
Specimen Handling
10
X-Rays
7
Biopsy
7
Nuclear Medicine Department, Hospital
6
Phantoms, Imaging
5
erdafitinib
4
Radiation
4
ulixertinib
3
trametinib
3
larotrectinib
3
dabrafenib
3
Radiotherapy
3
tipifarnib
2
selpercatinib
2
palbociclib
2
ivosidenib
2
ensartinib
2
binimetinib
2
Surgical Procedures, Operative
2
Nivolumab
2
veliparib
1
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
temsirolimus
1
tazemetostat
1
selinexor
1
sapanisertib
1
ribociclib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Glioma
×
lorlatinib
×
30 days
×
Clear all
No trials found.